Case Studies - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Case Studies

JDA Software Group, Inc.

April 1, 2009

Merck Serono?s biggest challenge was the integration of two very different supply chains for traditional pharmaceuticals and biotechnology-based pharmaceuticals.

Clean utilities at Leo Pharma

January 6, 2009

Leo Pharma at Vernouillet in France produces the anti-thrombotic Innohep® in pre-filled syringes, and blister packed tablets of the diuretics Burinex® and Centyl® and the antibiotic Fucidine®.

Global Information Management Solution from SDL

January 6, 2009

The following case study looks at how SDL?s Global Information Management System (GIM) has enabled the European Medicines Agency (EMEA) and GlaxoSmithKline (GSK) to work together to help perfect the new European healthcare standard, Product Information Management, and create a streamlined, efficient process for the approval of new drugs and products.

Introducing an automated and validated calibration system

July 28, 2008

AstraZeneca Sweden Operations

11,000 calibrations a year, made mostly with Beamex calibration equipment

July 28, 2008

Eli Lilly and Compny Limited, Speke Operations United Kingdom

IT Governance smoothes the way to IS027001 certification for IMS Hospital Group

July 28, 2008

IT Governance smoothes the way to IS027001 certification for IMS Hospital Group.

Paperless calibaration system — the choice of an enviornmentally conscious pharmaceutical company

July 23, 2008

Paperless calibaration system — the choice of an enviornmentally conscious pharmaceutical company

Modular Cleanroom Construction Makes the Difference at St. Georges Hospital

July 23, 2008

Modular Cleanroom Construction Makes the Difference at St. Georges Hospital

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
Click here